JUNCTURE WEALTH STRATEGIES, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 4 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JUNCTURE WEALTH STRATEGIES, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2023$1,162,533
+42.7%
18,796
+6.1%
0.53%
+32.7%
Q3 2023$814,529
-11.0%
17,711
+11.3%
0.40%
-7.0%
Q2 2023$914,693
+13.7%
15,916
-25.8%
0.43%
+8.1%
Q1 2023$804,488
+133.3%
21,453
+74.3%
0.40%
+141.5%
Q4 2022$344,786
+0.5%
12,305
+0.8%
0.16%
-4.1%
Q3 2022$343,000
+69.0%
12,208
+109.4%
0.17%
+71.0%
Q2 2022$203,0005,8290.10%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders